Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells

Background. A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), althoug...

Full description

Bibliographic Details
Main Authors: Clutterbuck, Elizabeth A., Lazarus, Rajeka, Yu, Ly-Mee, Bowman, Jaclyn, Bateman, Elizabeth A. L., Diggle, Linda, Angus, Brian, Peto, Tim E., Beverley, Peter C., Mant, David, Pollard, Andrew J.
Format: Online
Language:English
Published: Oxford University Press 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324398/
id pubmed-3324398
recordtype oai_dc
spelling pubmed-33243982012-04-12 Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells Clutterbuck, Elizabeth A. Lazarus, Rajeka Yu, Ly-Mee Bowman, Jaclyn Bateman, Elizabeth A. L. Diggle, Linda Angus, Brian Peto, Tim E. Beverley, Peter C. Mant, David Pollard, Andrew J. Major Articles and Brief Reports Background. A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), although highly effective in infants, offer any immunological advantages over 23vP in adults. Oxford University Press 2012-05-01 2012-03-28 /pmc/articles/PMC3324398/ /pubmed/22457293 http://dx.doi.org/10.1093/infdis/jis212 Text en © The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Clutterbuck, Elizabeth A.
Lazarus, Rajeka
Yu, Ly-Mee
Bowman, Jaclyn
Bateman, Elizabeth A. L.
Diggle, Linda
Angus, Brian
Peto, Tim E.
Beverley, Peter C.
Mant, David
Pollard, Andrew J.
spellingShingle Clutterbuck, Elizabeth A.
Lazarus, Rajeka
Yu, Ly-Mee
Bowman, Jaclyn
Bateman, Elizabeth A. L.
Diggle, Linda
Angus, Brian
Peto, Tim E.
Beverley, Peter C.
Mant, David
Pollard, Andrew J.
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
author_facet Clutterbuck, Elizabeth A.
Lazarus, Rajeka
Yu, Ly-Mee
Bowman, Jaclyn
Bateman, Elizabeth A. L.
Diggle, Linda
Angus, Brian
Peto, Tim E.
Beverley, Peter C.
Mant, David
Pollard, Andrew J.
author_sort Clutterbuck, Elizabeth A.
title Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
title_short Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
title_full Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
title_fullStr Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
title_full_unstemmed Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
title_sort pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific b cells
description Background. A 23-valent unconjugated pneumococcal polysaccharide vaccine (23vP), routinely administered at the age of 65, has limited effectiveness, and revaccination induces attenuated antibody responses. It is not known whether pneumococcal polysaccharide-protein conjugated vaccines (PCV), although highly effective in infants, offer any immunological advantages over 23vP in adults.
publisher Oxford University Press
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324398/
_version_ 1611520429032210432